Syncom Formulations (India)

Syncom Formulations India Limited is a recognised name in the Indian pharmaceutical industry, representing a synergistic blend of commitment and consistency. The company's vision is to leverage the fast-growing pharmaceutical market by investing in new units for injectables and critical care to reach new geographies. It operates from a state-of-the-art WHO-GMP and ISO 9001-2015 certified plant, ensuring high quality standards with the latest production machinery. The company's business is segmented into manufacturing pharmaceutical drugs, trading commodities, and renting out properties for income. As a key player, it contributes to India being a top producer of generic medicines, which accounts for 20% of the global supply by volume. Furthermore, the company plays a role in India’s position as a leading vaccine manufacturer, which holds a dominant 60% share of the global market.;